CBD-coronavirus Misinformation Is Already Here
Cannabidiol (CBD) has gained a reputation as something of a “cure-all.” Its
Perhaps it’s no surprise then that, as the coronavirus spreads around the world, CBD misinformation has followed. One unlicensed CBD brand in Canada has claimed it can help defend against coronavirus, while another CBD retailer in Idaho
Clinical evidence for CBD as an effective antiviral
, though there are a small handful of preclinical studies that suggest the cannabinoid could be of use in treating and . Still, there is that the compound could be useful in tackling COVID-19 in the same way.
The theoretical attraction of CBD
Some experts believe that CBD products might experience a small boost in sales at this time, as those familiar with the products include them in their shopping trips to stock up on essentials during periods of self-isolation.
With COVID-19 causing pneumonia-like symptoms, such as fever, there would appear to be some logic behind the idea that CBD could be helpful. After all,
Orally administered CBD has also been shown to improve the condition of patients with
In March of this year, there were several claims that such anti-inflammatory painkillers, such as ibuprofen, could make cases of coronavirus worse. However, these concerns have since been largely put to rest. The UK's Commission on Human Medicines has confirmed there is no clear evidence that using ibuprofen to treat symptoms such as a high temperature can make coronavirus worse.
“Zero evidence” to suggest CBD can manage COVID-19
That said, it’s important to recognize that there is currently no scientific research or clinical evidence suggesting that CBD could be effective in safely managing any specific symptoms of COVID-19.
“There is currently absolutely no evidence that CBD can play any role in altering the course of coronavirus (COVID-19) disease and I would strongly urge the CBD industry to stay far away from making any suggestion, however subtle, that it does,” Dr Andy Yates, science lead at the Association for the Cannabinoid Industry, told
Last week, one CBD retailer in Idaho
The herbalist didn’t mention coronavirus in relation to any of their CBD products, although the website did include a listing from another herbalist which detailed a “coronavirus protocol” recommending the use of herbal supplements. In response, the US Food and Drug Administration (FDA) issued an
FDA Commissioner Stephen Hahn has said that the agency will be
“During a time of serious national and international challenges our industry needs to show leadership and a strong moral compass and do the right thing,” Yates added.
“If companies are interested in researching the potential anti-inflammatory or other effects of CBD in coronavirus or any other disease state then they should make the investment in doing the proper research to generate data and publish that data in peer-reviewed scientific or clinical journals for others to access and build upon.”